Literature DB >> 3943184

Apolipoprotein E quantified by enzyme-linked immunosorbent assay.

J Bury, R Vercaemst, M Rosseneu, F Belpaire.   

Abstract

We developed a sensitive, specific "sandwich"-type enzyme-linked immunosorbent assay in which affinity-purified antibodies are used for coating and also for preparing an antibody-peroxidase conjugate to quantify apolipoprotein E in serum and in its lipoprotein fractions. This technique is rapid (results within 5 h), precise (mean intra- and interassay CVs 4.3 and 8.2%, respectively), accurate, and simple to perform. Sample pretreatment did not enhance apo E immunoreactivity. For 47 normolipidemic subjects, the mean apo E concentration was 38.11 (SD 11.1) mg/L. Above-normal apo E concentrations were measured in all types of hyperlipoproteinemia, especially types III and V. Apo E correlated with triglyceride (r = 0.58) and cholesterol concentrations (r = 0.60). As determined by gel filtration, hypertriglyceridemia was associated with a redistribution of apo E towards the triglyceride-rich lipoprotein fractions, which contained 77.1% (SD 16.8%) of total plasma apo E in Fredrickson type V patients, compared with 12.5% (SD 6.3%) in normal persons.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3943184

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  6 in total

1.  Apolipoprotein E polymorphism in The Netherlands and its effect on plasma lipid and apolipoprotein levels.

Authors:  M Smit; P de Knijff; M Rosseneu; J Bury; E Klasen; R Frants; L Havekes
Journal:  Hum Genet       Date:  1988-11       Impact factor: 4.132

2.  The effect of the apolipoprotein E phenotype on plasma lipids is not influenced by environmental variability: results of a Dutch twin study.

Authors:  P de Knijff; D I Boomsma; E de Wit; H J Kempen; J A Gevers Leuven; R R Frants; L M Havekes
Journal:  Hum Genet       Date:  1993-04       Impact factor: 4.132

3.  Familial dysbetalipoproteinemia associated with apolipoprotein E3-Leiden in an extended multigeneration pedigree.

Authors:  P de Knijff; A M van den Maagdenberg; A F Stalenhoef; J A Leuven; P N Demacker; L P Kuyt; R R Frants; L M Havekes
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

4.  The apolipoprotein m-sphingosine-1-phosphate axis: biological relevance in lipoprotein metabolism, lipid disorders and atherosclerosis.

Authors:  Bas W C Arkensteijn; Jimmy F P Berbée; Patrick C N Rensen; Lars B Nielsen; Christina Christoffersen
Journal:  Int J Mol Sci       Date:  2013-02-25       Impact factor: 5.923

5.  Plasma levels of apolipoprotein-E in residents of the European North of Russia.

Authors:  Anastasiya M Kaneva; Evgeny R Bojko; Natalya N Potolitsyna; Jon O Odland
Journal:  Lipids Health Dis       Date:  2013-03-27       Impact factor: 3.876

6.  The association of telomere length with paternal history of premature myocardial infarction in the European Atherosclerosis Research Study II.

Authors:  Klelia D Salpea; Viviane Nicaud; Laurence Tiret; Philippa J Talmud; Steve E Humphries
Journal:  J Mol Med (Berl)       Date:  2008-04-15       Impact factor: 4.599

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.